prnewswire.comBreakthrough Cancer Therapies Fuel Regulatory Momentum as Global Market Expands3 days ago
businesswire.comZai Lab Announces Acceptance of New Drug Application for KarXT for the Treatment of Schizophrenia8 months ago
businesswire.comZai Lab and Vertex Announce Strategic Agreement to Develop and Commercialize Povetacicept in Mainland China, Hong Kong SAR, Macau SAR, Taiwan region and Singapore8 months ago
businesswire.comVertex and Zai Lab Announce Strategic Agreement to Develop and Commercialize Povetacicept in Mainland China, Hong Kong SAR, Macau SAR, Taiwan Region and Singapore8 months ago
businesswire.comZai Lab Announces Strategic Partnership with MediLink Therapeutics to Develop a Novel LRRC15 Antibody-Drug Conjugate8 months ago
businesswire.comZai Lab Announces the Inclusion of AUGTYRO (repotrectinib) for ROS1+ NSCLC and Other Updates in China’s National Reimbursement Drug List9 months ago
businesswire.comZai Lab and Pfizer Announce Strategic Collaboration on the Novel Antibacterial Drug XACDURO (Sulbactam-Durlobactam)10 months ago
businesswire.comZai Lab Announces Pricing of Public Offering of American Depositary Shares10 months ago
CashuZai Lab and Amgen's Bemarituzumab Trial Aims to Transform Gastric Cancer Treatmentabout 4 hours ago
CashuOncolytics Advances Pelareorep Immunotherapy, Boosting Prospects for Zai Lab in Oncology Market1 day ago
CashuZai Lab Positioned for Growth Amid Oncolytics' Immunotherapy Advancements in Pancreatic Cancer3 days ago